title: [Dyspepsia and Helicobacter pylori: should it be treated?].
abstract: Epigastric pains are currently one of the most frequent reasons of clinic visits in ambulatory medicine, generating high direct and indirect costs each year. Corresponding to pains in the epigastric area, they result from different underlying diseases such as gastro-esophageal reflux, dyspepsia and peptic ulcers. If the role of Helicobacter pylori is well defined in the pathogenesis of gastro-duodenal ulcers, its implication in dyspepsia is less clear. The Maastricht IV Consensus recommends to test and treat Helicobacter pylori among patients with dyspepsia and no alarm symptoms.
authors.affiliation: Service de medecine de premier recours, Département de médecine communautaire, de premier recours et des urgences, HUG, 1211 Genève 14. laurence.rochat@hcuge.ch
authors.forename: L
authors.initials: L
authors.lastname: Rochat
authors.forename: A
authors.initials: A
authors.lastname: Keta
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000209:etiology*; D016481:Helicobacter Infections / Q000175:diagnosis / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D010437:Peptic Ulcer / Q000188:drug therapy / Q000382:microbiology
chemical_list: D000900:Anti-Bacterial Agents